-
41
-
42
-
43
-
44
-
45
Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, dou...
Published 2022-06-01“…Funding: This study was funded by MODAG GmbH and by the Michael J. Fox foundation for Parkinson's Research.…”
Get full text
Article -
46
Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clin...
Published 2024-03-01“…Funding: The Michael J Fox Foundation for Parkinson’s Research, Shake IT Up Australia, National Health and Medical Research Council, and Australian Research Council.…”
Get full text
Article -
47
-
48
Mitochondrial DNA deletions in the cerebrospinal fluid of patients with idiopathic REM sleep behaviour disorderResearch in context
Published 2024-04-01“…Funding: Funded by Michael J. Fox Foundation research grant MJFF-001111. Funded by MICIU/AEI/10.13039/501100011033 “ERDF A way of making Europe”, grants PID2020-115091RB-I00 (RT) and PID2022-143279OB-I00 (ACo). …”
Get full text
Article